Current Vascular Pharmacology

Journal Title：Current Vascular Pharmacology

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

《当代血管药理学》发表临床和研究综述/小综述、原创研究文章、信件、辩论、药物临床试验研究和特邀编辑的问题，以更新所有关注血管疾病治疗的人，弥合临床实践与正在进行的研究之间的差距。

血管疾病是西方国家最常见的死亡原因，其发病率在发展中国家呈上升趋势。因此，大量研究旨在建立有效的急性血管事件治疗方法。长期治疗也受到了广泛关注（例如用于缓解症状）。此外，有效的预防，无论是初级还是次级的，都得到了几项具有里程碑意义的试验结果的支持。血管疾病是一个复杂的领域，涉及初级保健医生和执业护士以及几个专业。后者包括心脏病学、血管和心胸外科、普通医学、放射学、临床药理学和神经病学（卒中科）。

Current Vascular Pharmacology创刊于2003年，由Bentham Science Publishers B.V.出版商出版，收稿方向涵盖医学 - 外周血管病全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 较慢,6-12周 ，影响因子指数2.8，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。